High Risk. High Reward: Cannabis Inc.

CNBC’s Melissa Lee investigates the booming cannabis industry, a market expected to hit $83 billion in the U.S. by 2025, thanks in part to marijuana’s new reputation as an all-natural cure for illness, boredom and just about everything in between. While some believe the industry is poised for another round of explosive growth, others are sounding the alarm. CNBC gains unprecedented access to some of pot’s biggest corporate players and explores the burning question: is cannabis the miracle drug that consumers and investors are banking on, or is it the product of misleading marketing by an industry where nothing is quite as it seems?